Patents Assigned to SINOVEDA CANADA, INC.
  • FORMULAS COMPRISING HIGHLY SOLUBLE ELEMENTS AND VITAMIN FOR THE PREVENTION AND AMELIORATION OF OSTEOPOROSIS
    Publication number: 20140154332
    Abstract: The present invention provides methods of producing dosage forms for formulas of elemental compositions encompassing acetate salts of calcium, magnesium and zinc along with vitamin D3. The acetate salts could be extracted from natural sources such as pearls, coral, and oyster or compounded using synthetic materials. The dosage and ratio of calcium to magnesium was estimated using in vitro and in vivo estimations. The dosage for promoting bone health and alleviation of osteoporosis is about a quarter to a third of the conventional dose.
    Type: Application
    Filed: July 27, 2012
    Publication date: June 5, 2014
    Applicant: SINOVEDA CANADA, INC.
    Inventor: Yun Kau Tam
  • PREPARATION OF BOTANICAL EXTRACTS CONTAINING ABSORBABLE COMPONENTS USING PHARMACEUTICAL PLATFORM TECHNOLOGY
    Publication number: 20110177179
    Abstract: Processes describing approaches to prepare herbal extracts containing absorbables and/or precursors of absorbables are described. The procedures are based on the physiological events in the gastrointestinal tract. Improvement of component absorption can also be achieved by designing an appropriate extraction condition.
    Type: Application
    Filed: January 18, 2011
    Publication date: July 21, 2011
    Applicant: SINOVEDA CANADA, INC.
    Inventors: Yun Kau TAM, Yi-Chan James LIN, Brian Duff SLOLEY
  • FORMULAS COMPRISING HIGHLY SOLUBLE ELEMENTS AND VITAMINS FOR THE PREVENTION AND AMELIORATION OF OSTEOPOROSIS
    Publication number: 20100292194
    Abstract: The present invention provides formulas of elemental compositions encompassing acetate salts of calcium, magnesium and zinc along with vitamin D3. The acetate salts could be extracted from natural sources such as pearls, coral, and oyster or compounded using synthetic materials. The dosage and ratio of calcium to magnesium was estimated using in vitro and in vivo estimations. The dosage for promoting bone health and alleviation of osteoporosis is about a quarter to a third of the conventional dose.
    Type: Application
    Filed: July 28, 2010
    Publication date: November 18, 2010
    Applicant: SINOVEDA CANADA, INC.
    Inventors: Yun Kau TAM, Ge LIN